132 related articles for article (PubMed ID: 38889251)
1. Procedure Volume and Outcomes With WATCHMAN Left Atrial Appendage Occlusion.
Friedman DJ; Du C; Zimmerman S; Tan Z; Lin Z; Vemulapalli S; Kosinski AS; Piccini JP; Pereira L; Minges KE; Faridi KF; Masoudi FA; Curtis JP; Freeman JV
Circ Cardiovasc Interv; 2024 Jun; 17(6):e013466. PubMed ID: 38889251
[TBL] [Abstract][Full Text] [Related]
2. First experience with the Watchman FLX occluder for percutaneous left atrial appendage closure.
Seeger J; Birkemeyer R; Rottbauer W; Wöhrle J
Cardiovasc Revasc Med; 2017; 18(7):512-516. PubMed ID: 28495117
[TBL] [Abstract][Full Text] [Related]
3. Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes.
Dukkipati SR; Kar S; Holmes DR; Doshi SK; Swarup V; Gibson DN; Maini B; Gordon NT; Main ML; Reddy VY
Circulation; 2018 Aug; 138(9):874-885. PubMed ID: 29752398
[TBL] [Abstract][Full Text] [Related]
4. Operator Experience and Outcomes after Transcatheter Left Atrial Appendage Occlusion with the Watchman Device.
Sawant AC; Seibolt L; Sridhara S; Rodriguez J; Distler E; Murarka S; Lazkani M; Kumar A; Kanwar N; Prakash MPH; Wiesner P; Pershad A
Cardiovasc Revasc Med; 2020 Apr; 21(4):467-472. PubMed ID: 31501020
[TBL] [Abstract][Full Text] [Related]
5. Indications for Left Atrial Appendage Occlusion in the United States and Associated In-Hospital Outcomes: Results From the NCDR LAAO Registry.
Daimee UA; Wang Y; Masoudi FA; Varosy PD; Friedman DJ; Du C; Koutras C; Reddy VY; Saw J; Price MJ; Kusumoto FM; Curtis JP; Freeman JV
Circ Cardiovasc Qual Outcomes; 2022 Aug; 15(8):e008418. PubMed ID: 35959677
[TBL] [Abstract][Full Text] [Related]
6. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
[TBL] [Abstract][Full Text] [Related]
7. Real-world experience with the new Watchman FLX device: Data from two high-volume Sicilian centers. The FLX-iEST registry.
Vizzari G; Grasso C; Sardone A; Mazzone P; Laterra G; Frazzetto M; Sacchetta G; Micari A; Tamburino C; Contarini M
Catheter Cardiovasc Interv; 2022 Jul; 100(1):154-160. PubMed ID: 35592941
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous left atrial appendage occlusion using different technologies in the United Kingdom: A multicenter registry.
Betts TR; Leo M; Panikker S; Kanagaratnam P; Koa-Wing M; Davies DW; Hildick-Smith D; Wynne DG; Ormerod O; Segal OR; Chow AW; Todd D; Cabrera Gomez S; Kirkwood GJ; Fox D; Pepper C; Foran J; Wong T
Catheter Cardiovasc Interv; 2017 Feb; 89(3):484-492. PubMed ID: 27651124
[TBL] [Abstract][Full Text] [Related]
9. Catheter Ablation for Atrial Fibrillation in Patients With Watchman Left Atrial Appendage Occlusion Device: Results from a Multicenter Registry.
Turagam MK; Lavu M; Afzal MR; Vuddanda V; Jazayeri MA; Parikh V; Atkins D; Bommana S; DI Biase L; Horton R; Bai R; Swarup V; Cheng J; Natale A; Lakkireddy D
J Cardiovasc Electrophysiol; 2017 Feb; 28(2):139-146. PubMed ID: 27943538
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous Left Atrial Appendage Closure With the Watchman Device: Long-Term Results Up to 5 Years.
Wiebe J; Franke J; Lehn K; Hofmann I; Vaskelyte L; Bertog S; Sievert H
JACC Cardiovasc Interv; 2015 Dec; 8(15):1915-1921. PubMed ID: 26738659
[TBL] [Abstract][Full Text] [Related]
11. Utilization and adverse outcomes of percutaneous left atrial appendage closure for stroke prevention in atrial fibrillation in the United States: influence of hospital volume.
Badheka AO; Chothani A; Mehta K; Patel NJ; Deshmukh A; Hoosien M; Shah N; Singh V; Grover P; Savani GT; Panaich SS; Rathod A; Patel N; Arora S; Bhalara V; Coffey JO; O'Neill W; Makkar R; Grines CL; Schreiber T; Di Biase L; Natale A; Viles-Gonzalez JF
Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):42-8. PubMed ID: 25480543
[TBL] [Abstract][Full Text] [Related]
12. Procedural success and intra-hospital outcome related to left atrial appendage morphology in patients that receive an interventional left atrial appendage closure.
Fastner C; Behnes M; Sartorius B; Wenke A; El-Battrawy I; Ansari U; Gill IS; Borggrefe M; Akin I
Clin Cardiol; 2017 Aug; 40(8):566-574. PubMed ID: 28409845
[TBL] [Abstract][Full Text] [Related]
13. Comparative Safety of Transcatheter LAAO With the First-Generation Watchman and Next-Generation Watchman FLX Devices.
Price MJ; Friedman DJ; Du C; Wang Y; Lin Z; Curtis JP; Freeman JV
JACC Cardiovasc Interv; 2022 Nov; 15(21):2115-2123. PubMed ID: 36357014
[TBL] [Abstract][Full Text] [Related]
14. Procedural and Short-Term Results With the New Watchman FLX Left Atrial Appendage Occlusion Device.
Cruz-González I; Korsholm K; Trejo-Velasco B; Thambo JB; Mazzone P; Rioufol G; Grygier M; Möbius-Winkler S; Betts T; Meincke F; Sandri M; Schmidt B; Schmitz T; Nielsen-Kudsk JE
JACC Cardiovasc Interv; 2020 Dec; 13(23):2732-2741. PubMed ID: 33189641
[TBL] [Abstract][Full Text] [Related]
15. Impact of Peridevice Leak on 5-Year Outcomes After Left Atrial Appendage Closure.
Dukkipati SR; Holmes DR; Doshi SK; Kar S; Singh SM; Gibson D; Price MJ; Natale A; Mansour M; Sievert H; Houle VM; Allocco DJ; Reddy VY
J Am Coll Cardiol; 2022 Aug; 80(5):469-483. PubMed ID: 35902169
[TBL] [Abstract][Full Text] [Related]
16. Computed tomography measurement of the left atrial appendage for optimal sizing of the Watchman device.
Xu B; Betancor J; Sato K; Harb S; Abdur Rehman K; Patel K; Kumar A; Cremer PC; Jaber W; Rodriguez LL; Schoenhagen P; Wazni O
J Cardiovasc Comput Tomogr; 2018; 12(1):50-55. PubMed ID: 29223726
[TBL] [Abstract][Full Text] [Related]
17. Left atrial appendage closure in patients with prohibitive anatomy: Insights from PINNACLE FLX.
Ellis CR; Jackson GG; Kanagasundram AN; Mansour M; Sutton B; Houle VM; Kar S; Doshi S; Osorio J
Heart Rhythm; 2021 Jul; 18(7):1153-1161. PubMed ID: 33957090
[TBL] [Abstract][Full Text] [Related]
18. Bleeding Outcomes After Left Atrial Appendage Closure Compared With Long-Term Warfarin: A Pooled, Patient-Level Analysis of the WATCHMAN Randomized Trial Experience.
Price MJ; Reddy VY; Valderrábano M; Halperin JL; Gibson DN; Gordon N; Huber KC; Holmes DR
JACC Cardiovasc Interv; 2015 Dec; 8(15):1925-1932. PubMed ID: 26627989
[TBL] [Abstract][Full Text] [Related]
19. Intracardiac versus transesophageal echocardiography for left atrial appendage occlusion with watchman.
Frangieh AH; Alibegovic J; Templin C; Gaemperli O; Obeid S; Manka R; Holy EW; Maier W; Lüscher TF; Binder RK
Catheter Cardiovasc Interv; 2017 Aug; 90(2):331-338. PubMed ID: 27649848
[TBL] [Abstract][Full Text] [Related]
20. Device-Sizing and Associated Complications With Left Atrial Appendage Occlusion: Findings From the NCDR LAAO Registry.
Sandhu A; Varosy PD; Du C; Aleong RG; Tumolo AZ; West JJ; Tzou WS; Curtis JP; Freeman JV; Friedman DJ; Hess PL
Circ Cardiovasc Interv; 2022 Dec; 15(12):e012183. PubMed ID: 36472194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
